Recombinant multi-species DCLRE1C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DCLRE1C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a nuclear protein that is involved in V(D)J recombination and DNA repair. The encoded protein has single-strand-specific 5'-3' exonuclease activity; it also exhibits endonuclease activity on 5' and 3' overhangs and hairpins. The protein also functions in the regulation of the cell cycle in response to DNA damage. Mutations in this gene can cause Athabascan-type severe combined immunodeficiency (SCIDA) and Omenn syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
The Alternative Names of target: 9930121L06Rik,A-SCID,Art,DCLRE1C,DCLREC1C,DNA cross-link repair 1C protein,Dclre1c,Protein A-SCID,Protein artemis,RS-SCID,SCIDA,SNM1 homolog C (hSNM1C),SNM1-like protein,SNM1C,Snm1l

Target products collectionGo to DCLRE1C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11217-Ag-1/ GM-Tg-hg-IP11217-Ag-2 Human DCLRE1C protein Human
GM-Tg-rg-IP11217-Ag-1/ GM-Tg-rg-IP11217-Ag-2 Rat DCLRE1C protein Rat
GM-Tg-mg-IP11217-Ag-1/ GM-Tg-mg-IP11217-Ag-2 Mouse DCLRE1C protein Mouse
GM-Tg-cynog-IP11217-Ag-1/ GM-Tg-cynog-IP11217-Ag-2 Cynomolgus/Rhesus macaque DCLRE1C protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11217-Ag-1/ GM-Tg-felg-IP11217-Ag-2 Feline DCLRE1C protein Feline
GM-Tg-cang-IP11217-Ag-1/ GM-Tg-cang-IP11217-Ag-2 Canine DCLRE1C protein Canine
GM-Tg-bovg-IP11217-Ag-1/ GM-Tg-bovg-IP11217-Ag-2 Bovine DCLRE1C protein Bovine
GM-Tg-equg-IP11217-Ag-1/ GM-Tg-equg-IP11217-Ag-2 Equine DCLRE1C protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11217-Ag-1/ GM-Tg-hg-IP11217-Ag-2; GM-Tg-rg-IP11217-Ag-1/ GM-Tg-rg-IP11217-Ag-2;
GM-Tg-mg-IP11217-Ag-1/ GM-Tg-mg-IP11217-Ag-2; GM-Tg-cynog-IP11217-Ag-1/ GM-Tg-cynog-IP11217-Ag-2;
GM-Tg-felg-IP11217-Ag-1/ GM-Tg-felg-IP11217-Ag-2; GM-Tg-cang-IP11217-Ag-1/ GM-Tg-cang-IP11217-Ag-2;
GM-Tg-bovg-IP11217-Ag-1/ GM-Tg-bovg-IP11217-Ag-2; GM-Tg-equg-IP11217-Ag-1/ GM-Tg-equg-IP11217-Ag-2
Products Name DCLRE1C protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DCLRE1C
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DCLRE1C protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.